Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Scientists demonstrate new method for discovering cancer gene function

08.08.2003


Using a new approach for dissecting the complicated interactions among many genes, scientists at Dana-Farber Cancer Institute have discovered how a common cancer gene works in tandem with another gene to spur the unchecked growth of cells. The researchers say the technique was so useful in solving a longstanding puzzle that it may expedite the discovery of other such gene interactions that lead to cancer, and could accelerate the development of new cancer drugs.



The report in the Aug. 8 issue of Cell describes how the method was used in identifying what additional genes are affected by the common oncogene, cyclin D1, when it makes too much of its normal protein. By combining two types of data and applying a powerful statistical tool, the researchers pinpointed an unsuspected gene, C/EBP-beta, as a key mediator of cyclin D1 action.

Justin Lamb, PhD, a molecular biologist at Dana-Farber and lead author of the report, said the previous experimental efforts had failed to identify genetic accomplices of cyclin D1 in triggering cancer. "We didn’t know what cyclin D1 was interacting with," said Lamb.


Sridhar Ramaswamy, MD, second author of the paper and the developer of a human tumor database used in the experiment, said that even when similar cancer gene interactions had been discovered in the laboratory, "the open question has been whether what is found in the test tube is what really happens in human tumors. The patterns of gene expression we found in human tumors corroborated our in vitro finding, and I think that the paper represents a proof of concept of the approach."

The research was carried out in the laboratory of Mark E. Ewen, PhD, senior author of the paper.

Cancer is now viewed as a set of diseases fundamentally caused by mutations in genes that normally regulate all aspects of cellular function. Dozens of mutated oncogenes are known: some overproduce a growth signal to produce runaway cell division, while others fail to exert their normal check on excessive growth.

Oncogenes, however, don’t act alone. Their aberrant signals are relayed through other genes that interact in complex cascades, akin to a bucket brigade used to fight a fire. Lab procedures used to sort out which genes (actually, the proteins they produce) connect with each other rely on cancer cells in culture. This is not necessarily comparable to cells from a human patient. These studies are also time-consuming and require highly skilled scientists and technicians.

Lamb sought a way to combine, and perhaps shorten, this molecular biology approach with another strategy – one which would make use of data from the Global Cancer Map, a database established by Ramaswamy of information from hundreds of samples of human tumors and normal tissue.

For one arm of the experiment, the researchers artificially overexpressed cyclin D1 in human breast cancer cells in a test tube culture. They collected the genetic output of those cells, in the form of the RNA "messages" made by the thousands of genes in the cancer cells. The levels of some of these messages would have been altered by the action of the overexpressed cyclin D1 gene. To identify those messages, and the genes that produced them, the scientists placed RNA from the cancer cells on gene chips, or microarrays, which measure the activity of thousands of genes at once.

The gene chips identified 21 genes that were spurred into high gear by cyclin D1, making them prime suspects for being "downstream targets" of cyclin D1 overexpression. The scientists could then compare this 21 gene "expression signature" with gene activity in actual human tumors containing an overactive cyclin D1 gene. "The question was, could we find that same set of genes in human tumor samples," said Lamb. "If so, we would know if they were relevant in human cancer."

The activity of different genes in 190 human tumor samples was already profiled in the Global Cancer Map, and, using a statistical tool called the Kolmogorov-Smirnov metric, the scientists showed that the 21 genes identified by the gene chips correlated closely with human tumors having high expression levels of cyclin D1.

Finally, the scientists used the Kolmogorov-Smirnov tool again, this time to sort among the 16,000 different genes in tumors in the cancer map database, ranking each one of the 16,000 by its similarity in expression pattern to those in the 21-gene expression signature discovered in the laboratory cancer cells. The process can be likened to the results of an Internet search engine that ranks each "hit" by how closely it matches the keywords in the search.

It was this "data-mining" process that turned up the C/EBP-beta gene, which makes a protein known as a transcription factor, as a frequent co-conspirator with the genes in the cyclin D1 expression signature. The data strongly suggest, say the scientists, that the C/EBP-beta is involved in regulating genes affected by cyclin D1 overexpression, and is therefore likely a principal participant in a previously-unappreciated mechanism of cyclin D1 action.

"By inference," says Ramaswamy, "C/EBP-beta is required for cyclin D1 to exert its effect in human cancer." If so, the gene might be added to the list of targets in cancer cells that could be attacked with highly specific drugs.

Contact: Bill Schaller, william_schaller@dfci.harvard.edu

Bill Schaller | EurekAlert!
Further information:
http://www.dfci.harvard.edu
http://www.dana-farber.org

More articles from Life Sciences:

nachricht Ambush in a petri dish
24.11.2017 | Friedrich-Schiller-Universität Jena

nachricht Meadows beat out shrubs when it comes to storing carbon
23.11.2017 | Norwegian University of Science and Technology

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New proton record: Researchers measure magnetic moment with greatest possible precision

High-precision measurement of the g-factor eleven times more precise than before / Results indicate a strong similarity between protons and antiprotons

The magnetic moment of an individual proton is inconceivably small, but can still be quantified. The basis for undertaking this measurement was laid over ten...

Im Focus: Frictional Heat Powers Hydrothermal Activity on Enceladus

Computer simulation shows how the icy moon heats water in a porous rock core

Heat from the friction of rocks caused by tidal forces could be the “engine” for the hydrothermal activity on Saturn's moon Enceladus. This presupposes that...

Im Focus: Nanoparticles help with malaria diagnosis – new rapid test in development

The WHO reports an estimated 429,000 malaria deaths each year. The disease mostly affects tropical and subtropical regions and in particular the African continent. The Fraunhofer Institute for Silicate Research ISC teamed up with the Fraunhofer Institute for Molecular Biology and Applied Ecology IME and the Institute of Tropical Medicine at the University of Tübingen for a new test method to detect malaria parasites in blood. The idea of the research project “NanoFRET” is to develop a highly sensitive and reliable rapid diagnostic test so that patient treatment can begin as early as possible.

Malaria is caused by parasites transmitted by mosquito bite. The most dangerous form of malaria is malaria tropica. Left untreated, it is fatal in most cases....

Im Focus: A “cosmic snake” reveals the structure of remote galaxies

The formation of stars in distant galaxies is still largely unexplored. For the first time, astron-omers at the University of Geneva have now been able to closely observe a star system six billion light-years away. In doing so, they are confirming earlier simulations made by the University of Zurich. One special effect is made possible by the multiple reflections of images that run through the cosmos like a snake.

Today, astronomers have a pretty accurate idea of how stars were formed in the recent cosmic past. But do these laws also apply to older galaxies? For around a...

Im Focus: Visual intelligence is not the same as IQ

Just because someone is smart and well-motivated doesn't mean he or she can learn the visual skills needed to excel at tasks like matching fingerprints, interpreting medical X-rays, keeping track of aircraft on radar displays or forensic face matching.

That is the implication of a new study which shows for the first time that there is a broad range of differences in people's visual ability and that these...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Ecology Across Borders: International conference brings together 1,500 ecologists

15.11.2017 | Event News

Road into laboratory: Users discuss biaxial fatigue-testing for car and truck wheel

15.11.2017 | Event News

#Berlin5GWeek: The right network for Industry 4.0

30.10.2017 | Event News

 
Latest News

IceCube experiment finds Earth can block high-energy particles from nuclear reactions

24.11.2017 | Physics and Astronomy

A 'half-hearted' solution to one-sided heart failure

24.11.2017 | Health and Medicine

Heidelberg Researchers Study Unique Underwater Stalactites

24.11.2017 | Earth Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>